Grifols SA

Type: Company
Name: Grifols SA (Grifols S.A)
Nationality: Spain
Web Address: http://www.grifols.com/
Fact Sheet: Fact Sheet for Grifols SA
First reported 2 hours ago - Updated 1 hour ago - 1 reports

NVS: Novartis Misses Sales Estimates, Stock Falls

Days after it announced a massive business overhaul, Novartis ( NVS ) stock is down after the pharmaceutical company saw weaker-than-expected earnings.NVS reported $14.02 billion in first-quarter sales, with analysts’ average estimates being $14.25 b ... [Published InvestorPlace.com - 2 hours ago]
First reported 9 hours ago - Updated 1 hour ago - 1 reports

Novartis' Q1 net income rises on sale of blood transfusion diagnostics unit

Novartis said Thursday that net income for the first quarter jumped 24 percent to just under $3 billion as the company recorded a $900 million gain from the divestment of its blood transfusion diagnostics unit to Grifols for $1.7 billion. Overall revenue ... [Published FirstWord Pharma - 9 hours ago]
First reported 8 hours ago - Updated 6 hours ago - 4 reports

Novartis sees net profit jump

Geneva - Swiss pharmaceuticals giant Novartis on Thursday posted a 24% jump in first-quarter net profit, driven largely by the sale of a blood transfusion diagnostics unit.The company, which earlier this week announced an extreme make-over of its structure, ... [Published Finance 24 - 7 hours ago]
First reported Apr 22 2014 - Updated Apr 23 2014 - 4 reports

GRIFOLS : Los Angeles site is awarded 'Highly Protected Risk (HPR)' status

Release date- 22042014 - Barcelona , : Grifols (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS), a leader in the production of plasma-derived medicines, achieved the 'Highly Protected Risk' (HPR) certification at its Los Angeles site, the highest recognition an industrial ... [Published 4 Traders - Apr 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 1 reports

Grifols And Japanese Red Cross Sign Blood Screening Deal

News: Spanish drugmaker Grifols has signed a US$375mn deal with Japan's Red Cross Society (JRC) to conduct blood analysis for the humanitarian organisation over the next seven years, reports Reuters. Under the terms of the deal, the company will conduct ... [Published Business Monitor International - Apr 23 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Grifols Celebrates World Hemophilia Day with Donation of Coagulation Medicines to the World Federation of Hemophilia

/PRNewswire/ -- Grifols, S.A. (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) today announced that it will donate up to 20 million units of coagulation therapies in each of the next three (3) years to the World Federation of Hemophilia (WFH). Grifols has been ... [Published Asian Hospital & Healthcare Management - Apr 21 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Fluor-Designed and Built Plasma Fractionation Facility Awarded ISPE 2014 Facility of the Year for Project Execution

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- "Fluor provides project management and execution excellence for pharmaceutical and biotech clients across the globe, and the Grifols blood plasma facility in North Carolina is ... [Published NewsRX - Apr 18 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 2 reports

Grifols Celebrates World Hemophilia Day with Donation of Coagulation Medicines to the World Federation of Hemophilia

/PRNewswire/ -- Grifols, S.A. (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) today announced that it will donate up to 20 million units of coagulation therapies in each of the next three (3) years to the World Federation of Hemophilia (WFH). Grifols has been ... [Published TickerTech.com - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Strength Seen in Apricus Biosciences (APRI): Stock Soars 18.9%

Apricus Biosciences, Inc. ( APRI ) was a big mover last session, as the company saw its shares rise almost 19% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for ... [Published Yahoo! Finance - Apr 17 2014]
First reported Apr 15 2014 - Updated Apr 16 2014 - 2 reports

Grifols' North Fractionation Named 2014 Facility of the Year for Project Execution

Fluor Corp. announced that Grifols' North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical Engineering 2014 Facility of the Year for Project Execution. According to a release, Fluor provided integrated engineering, ... [Published Individual.com - Apr 16 2014]
First reported Apr 10 2014 - Updated Apr 11 2014 - 4 reports

Fluor-Designed And Built Plasma Fractionation Facility Awarded ISPE 2014 Facility Of The Year For Project Execution

Home /News / Oil and Gas / Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical Engineering (ISPE) 2014 Facility of the Year for Project Exec ... [Published EPC Engineer - Apr 11 2014]
First reported Apr 04 2014 - Updated Apr 05 2014 - 12 reports

Annual Report for 2013 on Form 20-F filed with the SEC on April 4 2014

/CNW/ - Grifols, S.A. ("Grifols") (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS), announced that it has filed its 2013 Annual Report on Form 20-F with the United States Securities and ... ... [Published Big News Network - Apr 05 2014]

Quotes

...Meanwhile, quarterly sales rose 1 percent to $14 billion, missing analyst projections of $14.2 billion. CEO Joe Jimenez said Novartis "delivered a solid quarter, with all divisions contributing to growth."
About the most thrilling assessment came from CEO Joe Jimenez--and we use "thrilling" as a relative term. "We're off to a good start in the fiscal year" he said
Commenting on the results, Joseph Jimenez, CEO of Novartis, said: "Novartis delivered a solid quarter, with all divisions contributing to growth. We made progress in innovation, including EU and US approval of Xolair [omalizumab] in chronic spontaneous urticaria and significant milestones for Bexsero. The transformational deals announced on Tuesday position the company for future success based on our sharpened focus, innovation power and financial strength."

More Content

All (172) | News (149) | Reports (0) | Blogs (15) | Audio/Video (0) | Fact Sheets (2) | Press Releases (6)
sort by: Date | Relevance
Novartis' Q1 net income rises on sale of blood ... [Published FirstWord Pharma - 1 hour ago]
NVS: Novartis Misses Sales Estimates, Stock Falls [Published InvestorPlace.com - 2 hours ago]
No big thrill from Novartis in Q1, just a 'soli... [Published FiercePharma - 2 hours ago]
Pharma giant Novartis sees net profit jump [Published MSN New Zealand - 6 hours ago]
Novartis sees net profit jump [Published Finance 24 - 7 hours ago]
Novartis sees quarterly net profits jump 24% [Published RTE Online - 7 hours ago]
Pharma giant Novartis sees net profit jump 24% [Published Economic Times - 7 hours ago]
Pharma giant Novartis sees net profit jump 24pc [Published Business Recorder - 8 hours ago]
Novartis 1st-qtr net profit flat, sales shy of ... [Published Pharma Letter - 8 hours ago]
UPDATE 2-Novartis sales miss forecast as readie... [Published CNBC - 8 hours ago]
Novartis' Q1 net income rises on sale of blood ... [Published FirstWord Pharma - 9 hours ago]
UPDATE 1-Sale of blood transfusion test unit bo... [Published Reuters - 11 hours ago]
Novartis Q1 Profit Boosted By Divestment Gain; ... [Published RTTNews.com - 11 hours ago]
Global Peripheral Artery Occlusive Disease (PAO... [Published Individual.com - Apr 23 2014]
GRIFOLS : Los Angeles site is awarded 'Highly P... [Published 4 Traders - Apr 23 2014]
Grifols And Japanese Red Cross Sign Blood Scree... [Published Business Monitor International - Apr 23 2014]
Drugmakers From Novartis to Glaxo Do Big Deals ... [Published Washington Post - Apr 22 2014]
Grifols Los Angeles site is awarded "Highly Pro... [Published Mediaddress - Apr 22 2014]
GRIFOLS : Los Angeles site is awarded "Highly P... [Published 4 Traders - Apr 22 2014]
Grifols Los Angeles site is awarded "Highly Pro... [Published Noodls - Apr 22 2014]
UK Molecular Blood Typing, Grouping and Infecti... [Published Individual.com - Apr 22 2014]
France Molecular Blood Typing, Grouping and Inf... [Published Individual.com - Apr 22 2014]
2014 US Molecular Blood Typing, Grouping and In... [Published Individual.com - Apr 22 2014]
BUENA VISTA REGIONAL MEDICAL CENTER [Published Storm Lake Pilot Tribune - Apr 22 2014]
Grifols Celebrates World Hemophilia Day with Do... [Published Asian Hospital & Healthcare Management - Apr 21 2014]
Royalty Financing Partnering Terms and Agreemen... [Published SBWire - Apr 18 2014]
"Option and Evaluation Partnering Terms and Agr... [Published SBWire - Apr 18 2014]
Asset Purchase Terms and Agreements in Pharma, ... [Published SBWire - Apr 18 2014]
Recent Study: Personalized Medicine Partnering ... [Published Digital Journal - Apr 18 2014]
Fluor-Designed and Built Plasma Fractionation F... [Published NewsRX - Apr 18 2014]
1 2 3 4 5 6
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Grifols Celebrates World Hemophilia Day with Do... [Published PR Newswire: Policy & Public Interest - Apr 17 2014]
BARCELONA, Spain, April 17, 2014 /PRNewswire/ -- Grifols, S.A. (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) today announced that it will donate up to 20 million units of coagulation therapies in each of the next three (3) years to the World Federation of Hemophilia ...
Fluor-Designed and Built Plasma Fractionation F... [Published Business Wire Manufacturing News - Apr 10 2014]
IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical Engineering (ISPE) 2014 Facility of the Year for Project ...
Fluor-Designed and Built Plasma Fractionation F... [Published Business Wire News with Multimedia - Apr 10 2014]
IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical Engineering (ISPE) 2014 Facility of the Year for Project ...
Fluor-Designed and Built Plasma Fractionation F... [Published EON Manufacturing - Apr 10 2014]
IRVING, Texas--(EON: Enhanced Online News)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical Engineering (ISPE) 2014 Facility of the Year ...
Fluor-Designed and Built Plasma Fractionation F... [Published Business Wire Photo/Multimedia News - Apr 10 2014]
IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical Engineering (ISPE) 2014 Facility of the Year for Project ...
1 2 3

Press Releases

sort by: Date | Relevance
Zacks.com featured expert Kevin Matras highligh... [Published Financial Services - Mar 13 2014]
TiGenix: appoints Gri-Cel CEO Dirk Buscher and ... [Published GlobeNewswire: Advertising News - Dec 05 2013]
TiGenix Completes EUR 12 Million Capital Increa... [Published GlobeNewswire: Acquisitions News - Nov 22 2013]
TiGenix Raises EUR 12 million via a Private Pla... [Published GlobeNewswire: Acquisitions News - Nov 20 2013]
Grifols va acquérir les activités diagnostiques... [Published Financial Services - Nov 12 2013]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.